October is renowned for its potential to unsettle investors with significant market drops, a trend that continues from the previous month. Indeed, while certain stocks have shown an ability to weather volatility, some falling stocks are down and could still see greater declines. Here are three such stocks that have been down significantly recently and
admin
One way to get portfolio exposure to both fossil fuels and clean energy is by owning Exxon Mobil (NYSE:XOM) stock. To a certain extent, XOM’s success depends on the ups and downs of the petroleum industry. Not everyone wants to ride out the oil market’s waves, so consider the risks and potential rewards before investing in
The list of stocks hedge funds are buying is always lengthy but according to Morgan Stanley, hedge funds have been allocating capital to a select group of beaten down stocks on expectations that they will likely rebound in the coming months. Hedge funds are taking advantage of the 3% and 4% decline in European and
With Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) stock poised to benefit tremendously from the rapidly rebounding digital advertising market and the proliferation of artificial intelligence (AI), Alphabet’s shares are definitely worth buying at this point. What’s more, the company is growing rapidly, while the valuation of GOOG stock remains attractive. The U.S. Digital Ad Market’s Comeback and the
In this article DIS ZS XOM SPOT OWL Follow your favorite stocksCREATE FREE ACCOUNT An Exxon gas station sign in the Brooklyn borough of New York City, Oct. 6, 2023. Michael M. Santiago | Getty Images Check out the companies making headlines before the bell: Walt Disney — Shares of the media giant rose more
The USS Truxtun (DDG-103) destroyer sits in dry dock at the General Dynamics Corp. NASSCO shipyard facility on the Elizabeth River in Norfolk, Virginia, on Jan. 9, 2018. Luke Sharrett | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Spotify — Shares of the music streaming service company fell 2.5%
In this article AKRO PEP U PLTR Follow your favorite stocksCREATE FREE ACCOUNT Palantir headquarters in Palo Alto, California, May 10, 2023. David Paul Morris | Bloomberg | Getty Images Check out the companies making headlines in premarket trading. Palantir Technologies — Shares of the data analytics company added 2.3% on news that the U.S.
In this article HASI SQ TFC RIVN PEP SKX LHX PLTR Follow your favorite stocksCREATE FREE ACCOUNT A pedestrian walks past a display of Skechers shoes. David Paul Morris | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Skechers — The shoe company gained 2.6% after UBS reiterated its buy
In this article NOVO.B-DK PXD XOM Follow your favorite stocksCREATE FREE ACCOUNT The Mobil logo and gas prices are displayed at a Mobil gas station on October 28, 2022 in Los Angeles, California. Mario Tama | Getty Images Check out the companies making headlines in premarket trading. Plug Power — The battery stock added nearly
With the stock market slump since the start of August, investors have new opportunities to buy several leading blue-chip stocks at bargain prices. Many well-known companies and household names had share prices fall 10% or more since mid-summer, when all three major U.S. indices declined on renewed worries of sticky inflation, elevated interest rates, and
The early investors in Tesla have already minted money. However, the electric vehicle sector is likely to create more millionaires in the coming years. Given the fact that EVs are still at an early stage of adoption globally, headroom for growth is immense for some of the best EV companies. It’s time to focus on
Immediately following the initial shock of the COVID-19 pandemic, the narrative of low-volatility stocks admittedly didn’t make much sense. With the benefit of hindsight, we can see that the additional influx of cash that retail investors had poured into higher-risk ventures. As a result, the traditional safe stocks fell by the wayside, replaced with a
As investors and traders alike have settled into the “higher for longer” mindset for interest rates, U.S. equities have experienced a lot of selling pressure in recent weeks. The S&P 500 is down 2% in the last 3 months, while the Nasdaq has fallen 1.44%. However, bearish times can still present good moments to invest
While enterprises with diminutive market capitalizations tend to be high-risk, high-reward ventures, you can shift the odds in your favor with small-cap stocks with buy ratings. Thanks to the nod from Wall Street experts, you can feel a little bit more comfortable with the speculative step that you’re taking. Now, to be 100% clear, small-cap
Since going public in June 2021, SoFi Technologies (NASDAQ:SOFI) hasn’t met investor expectations. Despite a 59% drop from its IPO price, it rebounded in 2023, surging 98%. Before buying, it’s crucial to consider the pros and cons of this fintech stock. Moreover, SOFI has experienced a rollercoaster ride. Despite facing challenges due to the extended
Suffice it to say, Clorox (NYSE:CLX) is roundly unloved on Wall Street right now. The pessimism may continue for a little while longer, so don’t be too early if you’re planning to buy CLX stock. It shouldn’t be too much longer before a big window of opportunity opens up, however. Clorox is America’s famous seller
These seven stocks are in trouble. While the broader market struggles with ongoing interest rate hikes, constrained cash and more, these seven stocks suffer more than most. But all hope isn’t lost — if the companies can mount buyouts. Oftentimes, larger firms hunt for smaller firms with a semi-viable product or existing operational model for
The future of solar is bright and governments across the world are trying their best to achieve their goal to transition towards a carbon-free electric grid. This is spelling big things for solar stocks. While it is easier said than done, we have seen tremendous progress this year and I believe this momentum is set
The seal of the U.S. Securities and Exchange Commission hangs on the wall at SEC headquarters in Washington, June 24, 2011. Jonathan Ernst | Reuters Securities traders are gathering in Washington. The big topic: trying to figure out what the Securities and Exchange Commission is doing. You know it’s bad when one of the session topics is
A box of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk. George Frey | Reuters Check out the companies making big moves midday. Novo Nordisk — The Danish drugmaker stock added 5.5% after saying late Tuesday it was halting Ozempic’s kidney disease treatment trial after a committee said
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 449
- Next Page »